Literature DB >> 18362260

Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels.

Brent A Neuschwander-Tetri, Aynur Unalp, Michael H Creer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18362260      PMCID： PMC3670191          DOI： 10.1001/archinternmed.2007.131

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  8 in total

1.  Alanine aminotransferase levels: what's normal?

Authors:  Marshall M Kaplan
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

2.  Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children.

Authors:  Joel E Lavine; Jeffrey B Schwimmer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-02       Impact factor: 2.839

3.  Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease.

Authors:  Yoosoo Chang; Seungho Ryu; Eunju Sung; Yumi Jang
Journal:  Clin Chem       Date:  2007-02-01       Impact factor: 8.327

4.  International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section. The theory of reference values. Part 2. Selection of individuals for the production of reference values.

Authors:  C PetitClerc; P Wilding
Journal:  J Clin Chem Clin Biochem       Date:  1984-02

5.  Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.

Authors:  Sachin S Kunde; Audrey J Lazenby; Ronald H Clements; Gary A Abrams
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

6.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

7.  Metrological traceability of values for catalytic concentration of enzymes assigned to a calibration material.

Authors:  Francesca Canalias; Sandra Camprubí; Maribel Sánchez; F-Javier Gella
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

8.  Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study.

Authors:  Hyeon Chang Kim; Chung Mo Nam; Sun Ha Jee; Kwang Hyub Han; Dae Kyu Oh; Il Suh
Journal:  BMJ       Date:  2004-03-17
  8 in total
  36 in total

1.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

Authors:  Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

2.  Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data.

Authors:  N Husain; P Blais; J Kramer; M Kowalkowski; P Richardson; H B El-Serag; F Kanwal
Journal:  Aliment Pharmacol Ther       Date:  2014-08-26       Impact factor: 8.171

3.  Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit.

Authors:  Yaron Rotman; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2017-03-03       Impact factor: 17.425

4.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

5.  Upper limits of normal for alanine aminotransferase activity in the United States population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

6.  Comparison of hepatitis C virus testing strategies: birth cohort versus elevated alanine aminotransferase levels.

Authors:  Bryce D Smith; Anthony K Yartel
Journal:  Am J Prev Med       Date:  2014-09       Impact factor: 5.043

7.  Characterization of early hepatic injury in HCV-negative recipients of HCV-infected kidneys.

Authors:  Rafal D Mazur; Peter L Abt; Emily A Blumberg; Roy D Bloom; K Rajender Reddy; Peter P Reese; David S Goldberg
Journal:  Clin Transplant       Date:  2019-03-06       Impact factor: 2.863

8.  Elevated hepatic enzymes and incidence of venous thromboembolism: a prospective study.

Authors:  Aaron R Folsom; Pamela L Lutsey; Nicholas S Roetker; Wayne D Rosamond; Mariana Lazo; Susan R Heckbert; Saonli Basu; Mary Cushman; Elizabeth Selvin
Journal:  Ann Epidemiol       Date:  2014-09-08       Impact factor: 3.797

9.  Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the longitudinal assessment of bariatric surgery (LABS) study.

Authors:  David E Kleiner; Paul D Berk; Jesse Y Hsu; Anita P Courcoulas; David Flum; Saurabh Khandelwal; John Pender; Alfons Pomp; James Roerig; Laura L Machado; Bruce M Wolfe; Steven H Belle
Journal:  Semin Liver Dis       Date:  2014-04-29       Impact factor: 6.115

10.  Liver disease among children in Hawai'i diagnosed with metabolic syndrome.

Authors:  David E St-Jules; Corilee A Watters; James Davis; Sorrell H Waxman
Journal:  Hawaii J Med Public Health       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.